Retinopathy of Prematurity

Study to Assess the Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Compared to Laser Photocoagulation in Patients With Retinopathy of Prematurity

RAINBOW Study: RAnibizumab Compared With Laser Therapy for the Treatment of INfants BOrn Prematurely With Retinopathy of Prematurity

umBilical Or Adult Donor Red Blood Cells in Extremely Low Gestational Age Neonates and Retinopathy of Prematurity (BORN)

Synergistic Pharmacologic Intervention for Prevention of ROP (SPIPROP Study)

Molecularly Determined Treatment of Diffuse Intrinsic Pontine Gliomas (DIPG)

Docetaxel With Bevacizumab as First-Line Therapy in Treating Women With Stage IV Breast Cancer

A Study of Vincristine, Escalating Doses of Irinotecan, Temozolomide and Bevacizumab (Vit-b) in Pediatric and Adolescent Patients With Recurrent or Refractory Solid Tumors of Non-hematopoietic Origin

Use of Pan-vascular Endothelial Growth Factor Receptor (Pan-VEGF) Blockade for the Treatment of Retinopathy of Prematurity (ROP) (Compassionate Use BLOCK-ROP)

A 24-week Study Evaluating the Effectiveness and Safety of Lucentis® 0.2mg in Retinopathy of Prematurity Participants in China

Regulatory PMS Study for Lucentis® in Patients With Retinopathy of Prematurity

Mother Milk as a Eye Drop & Premature Retinopathy

Extension Study to Evaluate the Long-Term Outcomes of Pediatric Patients Who Received Treatment for Retinopathy of Prematurity in the VGFTe-ROP-1920 Study (Acronym: Butterfleye Next)

Registry for Severe ROP and Treatment on Visual Outcomes

Skin and Serum Carotenoids in Preterm Infants Fed on a Formula Supplemented With Carotenoids